Emyria Ltd: Becoming a substantial holder
Emyria Ltd: Ceasing to be a substantial holder
Emyria Ltd: Emyria, UWA Secure $499K Grant for MDMA Analogue Program
Emyria Ltd: Empax Centre Selected As Key Site In Global PTSD Study
Emyria Ltd: Management Changes
Emyria Ltd: Change in substantial holding
Emyria Ltd: Section 708A(5)(e) Notice
Emyria Ltd: Notification regarding unquoted securities - EMD
Emyria Ltd: Application for quotation of securities - EMD
Emyria Ltd: March 2024 Quarterly Activities Report and Appendix 4C
Emyria Ltd: Proposed issue of securities - EMD
Emyria Ltd: Emyria Receives Bids of $2.3M to Expand Clinical Services
Emyria Ltd: Trading Halt
Emyria Ltd: Emyria Opens Empax Centre to Advance Mental Health Care
Emyria Ltd: Emyria Expands Specialist AP Team - First Female for MDMA-AT
Emyria Ltd: Emyria, Reach Wellness Enter MDMA-AT Research Agreement
Emyria Ltd: Notification of cessation of securities - EMD
Emyria Ltd: Response to ASX Aware Query
Emyria Ltd: Response to ASX Price Query
Emyria Ltd: Emyria Half Year Results FY2024
No Data